Removal of Persistent Acid Pharmaceuticals by a Biological-Photocatalytic Sequential Process: Clofibric Acid, Diclofenac, and Indomethacin

The removal of three acid pharmaceuticals—clofibric acid (CLA), diclofenac (DCL), and indomethacin (IND)—by a biological-photocatalytic sequential system was studied. These pharmaceutical active compounds (PhACs) are considered to persist in the environment and have been found in water and sewage, producing adverse effects on the aquatic environment. For the biological process, in batch experiments, a fixed bed bioreactor and activated sludge (hybrid bioreactor), under aerobic conditions, was used as pretreatment. The pretreated effluent was exposed to a photocatalytic process employing TiO₂ nanotubular films (NTF-TiO₂) with the following characteristics: an internal diameter of 112 nm, a wall thickness of 26 nm, nanotube length of 15 µm, a roughness factor of 1840 points, and an anatase-rutile crystalline structure. In the hybrid bioreactor, 39% IND and 50% ACL and DCL were removed. The biological-photocatalysis sequential system achieved the degradation of up to 90% of the initial concentrations of the three acid pharmaceuticals studied. This approach appears to be a viable alternative for the treatment of these non-biodegradable effluents.